<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnmol.2023.1175522</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Altered exocytosis of inhibitory synaptic vesicles at single presynaptic terminals of cultured striatal neurons in a knock-in mouse model of Huntington&#x2019;s disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Xu</surname> <given-names>Chen</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Chen</surname> <given-names>Sidong</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/587350/overview"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Chen</surname> <given-names>Xingxiang</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ho</surname> <given-names>Ka Hei</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Park</surname> <given-names>Chungwon</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Yoo</surname> <given-names>Hanna</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Lee</surname> <given-names>Suk-Ho</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Park</surname> <given-names>Hyokeun</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/560368/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Division of Life Science, The Hong Kong University of Science and Technology</institution>, <addr-line>Kowloon</addr-line>, <country>Hong Kong SAR, China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Hong Kong Center for Construction Robotics (InnoHK-HKCRC), Hong Kong Science Park</institution>, <addr-line>Sha Tin</addr-line>, <country>Hong Kong SAR, China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Physiology, Seoul National University College of Medicine</institution>, <addr-line>Seoul</addr-line>, <country>Republic of Korea</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Physics, The Hong Kong University of Science and Technology</institution>, <addr-line>Kowloon</addr-line>, <country>Hong Kong SAR, China</country></aff>
<aff id="aff5"><sup>5</sup><institution>State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology</institution>, <addr-line>Kowloon</addr-line>, <country>Hong Kong SAR, China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Sangyong Jung, CHA University, Republic of Korea</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Sukwon Lee, Korea Brain Research Institute, Republic of Korea; Ferah Yildirim, Charit&#x00E9; University Medicine Berlin, Germany</p></fn>
<corresp id="c001">&#x002A;Correspondence: Hyokeun Park, <email>hkpark@ust.hk</email></corresp>
<fn fn-type="equal" id="fn002"><p><sup>&#x2020;</sup>These authors have contributed equally to this work</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>17</day>
<month>08</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>16</volume>
<elocation-id>1175522</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>02</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>07</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2023 Xu, Chen, Chen, Ho, Park, Yoo, Lee and Park.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Xu, Chen, Chen, Ho, Park, Yoo, Lee and Park</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>Huntington&#x2019;s disease (HD) is a progressive dominantly inherited neurodegenerative disease caused by the expansion of a cytosine-adenine-guanine (CAG) trinucleotide repeat in the <italic>huntingtin</italic> gene, which encodes the mutant huntingtin protein containing an expanded polyglutamine tract. One of neuropathologic hallmarks of HD is selective degeneration in the striatum. Mechanisms underlying selective neurodegeneration in the striatum of HD remain elusive. Neurodegeneration is suggested to be preceded by abnormal synaptic transmission at the early stage of HD. However, how mutant huntingtin protein affects synaptic vesicle exocytosis at single presynaptic terminals of HD striatal neurons is poorly understood. Here, we measured synaptic vesicle exocytosis at single presynaptic terminals of cultured striatal neurons (mainly inhibitory neurons) in a knock-in mouse model of HD (zQ175) during electrical field stimulation using real-time imaging of FM 1-43 (a lipophilic dye). We found a significant decrease in bouton density and exocytosis of synaptic vesicles at single presynaptic terminals in cultured striatal neurons. Real-time imaging of VGAT-CypHer5E (a pH sensitive dye conjugated to an antibody against vesicular GABA transporter (VGAT)) for inhibitory synaptic vesicles revealed a reduction in bouton density and exocytosis of inhibitory synaptic vesicles at single presynaptic terminals of HD striatal neurons. Thus, our results suggest that the mutant huntingtin protein decreases bouton density and exocytosis of inhibitory synaptic vesicles at single presynaptic terminals of striatal neurons, causing impaired inhibitory synaptic transmission, eventually leading to the neurodegeneration in the striatum of HD.</p>
</abstract>
<kwd-group>
<kwd>Huntington&#x2019;s disease</kwd>
<kwd>synaptic vesicle</kwd>
<kwd>exocytosis</kwd>
<kwd>inhibitory synapses</kwd>
<kwd>real-time imaging</kwd>
<kwd>presynaptic terminal</kwd>
</kwd-group>
<contract-num rid="cn001">16102322</contract-num>
<contract-num rid="cn001">N_HKUST613/17</contract-num>
<contract-num rid="cn002">ITCPD/17-9</contract-num>
<contract-sponsor id="cn001">Research Grants Council, University Grants Committee<named-content content-type="fundref-id">10.13039/501100002920</named-content></contract-sponsor>
<contract-sponsor id="cn002">Innovation and Technology Commission - Hong Kong<named-content content-type="fundref-id">10.13039/501100007156</named-content></contract-sponsor>
<counts>
<fig-count count="5"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="76"/>
<page-count count="10"/>
<word-count count="7850"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Brain Disease Mechanisms</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p>Huntington disease (HD) is a progressive dominantly inherited neurodegenerative disease caused by abnormally expanded cytosine-adenine-guanine (CAG) trinucleotide repeats in the first exon in the <italic>huntingtin</italic> (<italic>HTT</italic>) gene (<xref ref-type="bibr" rid="B24">The Huntington&#x2019;s Disease Collaborative Research Group, 1993</xref>), which encodes an anomalously expanded polyglutamine (polyQ) tract in the huntingtin protein. The symptoms of HD include abnormal involuntary movements, psychiatric disturbance, and cognitive impairment (<xref ref-type="bibr" rid="B60">Roos, 2010</xref>; <xref ref-type="bibr" rid="B19">Dayalu and Albin, 2015</xref>; <xref ref-type="bibr" rid="B41">McColgan and Tabrizi, 2018</xref>). Although the huntingtin protein is distributed throughout the body, inhibitory medium spiny neurons (MSNs) in the striatum are the most vulnerable neurons in HD (<xref ref-type="bibr" rid="B69">Vonsattel and DiFiglia, 1998</xref>).</p>
<p>Selective neurodegeneration of striatal neurons in HD was suggested to be associated with abnormal synaptic transmission (<xref ref-type="bibr" rid="B34">Klapstein et al., 2001</xref>; <xref ref-type="bibr" rid="B11">Cepeda et al., 2003</xref>; <xref ref-type="bibr" rid="B37">Li et al., 2003</xref>; <xref ref-type="bibr" rid="B64">Smith et al., 2005</xref>; <xref ref-type="bibr" rid="B56">Raymond et al., 2011</xref>; <xref ref-type="bibr" rid="B67">Tyebji and Hannan, 2017</xref>; <xref ref-type="bibr" rid="B15">Chen et al., 2018</xref>; <xref ref-type="bibr" rid="B68">Virlogeux et al., 2018</xref>; <xref ref-type="bibr" rid="B2">Barron et al., 2021</xref>; <xref ref-type="bibr" rid="B13">Chen S. et al., 2021</xref>; <xref ref-type="bibr" rid="B3">Barry et al., 2022</xref>; <xref ref-type="bibr" rid="B12">Cepeda and Levine, 2022</xref>), reduced availability of brain-derived neurotrophic factor (BDNF) to the striatum (<xref ref-type="bibr" rid="B75">Zuccato and Cattaneo, 2009</xref>, <xref ref-type="bibr" rid="B76">2014</xref>; <xref ref-type="bibr" rid="B51">Park, 2018</xref>; <xref ref-type="bibr" rid="B72">Yu et al., 2018</xref>), impaired mitochondrial function (<xref ref-type="bibr" rid="B9">Carmo et al., 2018</xref>; <xref ref-type="bibr" rid="B22">Franco-Iborra et al., 2018</xref>; <xref ref-type="bibr" rid="B62">Sawant et al., 2021</xref>), and abnormal Ca<sup>2+</sup> regulation (<xref ref-type="bibr" rid="B5">Bezprozvanny, 2009</xref>; <xref ref-type="bibr" rid="B43">Miller and Bezprozvanny, 2010</xref>; <xref ref-type="bibr" rid="B55">Raymond, 2016</xref>; <xref ref-type="bibr" rid="B15">Chen et al., 2018</xref>). Much research has focused on abnormal synaptic transmission in corticostriatal synapses and excitotoxicity in HD (<xref ref-type="bibr" rid="B64">Smith et al., 2005</xref>; <xref ref-type="bibr" rid="B55">Raymond, 2016</xref>; <xref ref-type="bibr" rid="B65">Smith-Dijak et al., 2019</xref>; <xref ref-type="bibr" rid="B12">Cepeda and Levine, 2022</xref>). Increased synaptic vesicle release was observed in cortical neurons in young HD mice (<xref ref-type="bibr" rid="B33">Joshi et al., 2009</xref>; <xref ref-type="bibr" rid="B15">Chen et al., 2018</xref>). Moreover, increased activity of extrasynaptic NMDA receptors was reported in acute slices obtained from the striatum of HD mice (<xref ref-type="bibr" rid="B44">Milnerwood et al., 2010</xref>) and was suggested to cause neurodegeneration in the striatum of HD (<xref ref-type="bibr" rid="B45">Milnerwood and Raymond, 2010</xref>; <xref ref-type="bibr" rid="B6">Botelho et al., 2014</xref>; <xref ref-type="bibr" rid="B58">Ribeiro et al., 2017</xref>). In addition to abnormal synaptic transmission in corticostriatal synapses in HD, recent findings suggested that abnormal synaptic transmission in GABAergic synapses may underlie HD pathogenesis (<xref ref-type="bibr" rid="B23">Garret et al., 2018</xref>; <xref ref-type="bibr" rid="B27">Hsu et al., 2018</xref>). Electrophysiology measurement showed altered striatal synaptic transmission in HD mice (<xref ref-type="bibr" rid="B16">Cummings et al., 2010</xref>). Furthermore, the expression level of GABA<sub>A</sub>R subunits was altered in HD mouse models (<xref ref-type="bibr" rid="B21">Du et al., 2017</xref>; <xref ref-type="bibr" rid="B48">Paraskevopoulou et al., 2021</xref>). However, how the mutant huntingtin protein affects exocytosis of inhibitory synaptic vesicles at single presynaptic terminals of HD striatal neurons is poorly understood.</p>
<p>In this study, we used real-time imaging of FM 1-43-loaded synaptic vesicles to measure synaptic vesicle exocytosis at single presynaptic terminals of cultured striatal neurons during electrical field stimulation. Bouton density and synaptic vesicle exocytosis were decreased at single presynaptic terminals in cultured striatal neurons (mainly inhibitory neurons) of a knock-in mouse model of HD (zQ175). Furthermore, real-time imaging of inhibitory synaptic vesicles containing VGAT-CypHer5E showed a decrease in bouton density and exocytosis of inhibitory synaptic vesicles at single presynaptic terminals in HD cultured striatal neurons. Thus, our results suggest that the mutant huntingtin protein decreases inhibitory bouton density and exocytosis of inhibitory synaptic vesicles at presynaptic terminals and alters synaptic transmission in the striatum at the early stage of HD, leading to selective neurodegeneration in the striatum of HD.</p>
</sec>
<sec id="S2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="S2.SS1">
<title>Mice</title>
<p>The zQ175 (a HD knock-in mouse model) mice were purchased from the Jackson Laboratories and were kept in the Animal and Plant Care Facility at the Hong Kong University of Science and Technology. Heterozygous zQ175 mice were utilized for breeding. All experimental procedures for mice were approved by the Department of Health, Government of Hong Kong and were performed following the approved protocols.</p>
</sec>
<sec id="S2.SS2">
<title>Culturing striatal neurons</title>
<p>Striatal tissue from postnatal day 0 (P0) heterozygous pups and wild-type (WT) littermates was used to culture HD and WT striatal neurons. Culturing striatal neurons was performed similarly as culturing cortical neurons (<xref ref-type="bibr" rid="B1">Alsina et al., 2017</xref>; <xref ref-type="bibr" rid="B15">Chen et al., 2018</xref>; <xref ref-type="bibr" rid="B13">Chen S. et al., 2021</xref>). Dissected striatal tissue was digested with papain (LS003127, Worthington Biochemical Corp., USA) and DNAse (D5025, Sigma-Aldrich, USA). Around 40000 striatal neurons were plated on each 12-mm glass coverslip coated with poly-D-lysine (P7405, Sigma-Aldrich) in 24-well plates (<xref ref-type="bibr" rid="B52">Park et al., 2012</xref>; <xref ref-type="bibr" rid="B15">Chen et al., 2018</xref>). At 3 days <italic>in vitro</italic> (DIV3), cultured striatal neurons were treated with 20 &#x03BC;M 5-Fluoro-2&#x2032;-deoxyuridine (FUDR, Sigma) to prevent the proliferation of glia cells. Cultured striatal neurons were grown at 37&#x00B0;C in a humidified incubator containing 5% CO<sub>2</sub> for at least 14 days. All experiments were performed between DIV14 and DIV16.</p>
</sec>
<sec id="S2.SS3">
<title>Immunofluorescence</title>
<p>Fixation of cultured striatal neurons was performed using ice-cold 100% methanol for 10 min. After washing with PBS three times and blocking with 5% goat serum in staining buffer (0.2% BSA, 0.8 M NaCl, 0.5% Triton X-100, 30 mM phosphate buffer, pH7.4), 50 &#x03BC;L of primary antibody mixtures containing polyclonal anti-MAP2 (1:1000, Ab5392 (Abcam)), monoclonal anti-DARPP32 (1:500, Ab40801 (Abcam)) and monoclonal anti-GAD67 (1:500, MAB5406 (Merck)) or monoclonal anti-VGLUT1 (1:500, MAB5502 (Merck)) were added to coverslips, and then striatal neurons were incubated at 4&#x00B0;C overnight. Then, following three times washing with PBS for 10 minutes, 1:1,000 diluted secondary antibodies containing goat anti-chicken-Alexa 488 (A11039 (Invitrogen)), goat anti-rabbit Alexa 568 (A11011 (Invitrogen)) and donkey anti-mouse Alexa 647 (A31571 (Invitrogen)) were added to the coverslips and incubate for 1 hour in room temperature in the following day. After washing three times, 250 nM DAPI (D1306 (Invitrogen)) was added and incubated for another 10 minutes at room temperature. After three times washing with PBS, coverslips were mounted on to Glass slides with HydroMount medium. Confocal images were acquired using a SP8 confocal microscope (Leica) with a 40X oil objective. The percentage of GAD67-positive neurons was calculated as the ratio of the number of GAD67-positive cells to the number of MAP2-positive cells. The percentage of VGLUT1-positive neurons was calculated as the ratio of the number of VGLUT1-positive cells to the number of MAP2-positive cells. The percentage of DARPP-32-positive neurons was calculated as the ratio of the number of DARPP-32-positive cells to the number of GAD67-positive cells. The numbers of MAP2-positive, GAD67-positive, VGLUT1-positive, and DARPP-32-positive cells were measured in a blinded manner.</p>
</sec>
<sec id="S2.SS4">
<title>Imaging of FM 1-43-loaded synaptic vesicles</title>
<p>Loading FM 1-43 into synaptic vesicles in cultured striatal neurons was performed by applying 1,200 external field stimuli at 10 Hz for 120 s in the presence of 16 &#x03BC;M FM 1-43 (T35356 (Thermo Fisher Scientific, USA)) in a sample chamber at 37&#x00B0;C with a platinum electrode wired to a stimulator (SD9 Grass Stimulator (Grass Technologies, USA)) as previously described (<xref ref-type="bibr" rid="B52">Park et al., 2012</xref>; <xref ref-type="bibr" rid="B15">Chen et al., 2018</xref>; <xref ref-type="bibr" rid="B13">Chen S. et al., 2021</xref>). After loading, the sample chamber was perfused for 10 min for washing with artificial cerebrospinal fluid (ACSF) solution containing (in mM): 120 NaCl, 4 KCl, 2 CaCl<sub>2</sub>, 2 MgCl<sub>2</sub>, 10 D-Glucose, and 10 HEPES (300-310 mOsm, pH 7.2-7.4 with NaOH). Exocytosis experiments of FM 1-43-loaded synaptic vesicles were performed as described previously (<xref ref-type="bibr" rid="B15">Chen et al., 2018</xref>). Images were obtained for 200 s at 1 Hz with an exposure time of 0.1 s with an EMCCD camera (iXon Ultra (Andor camera)). An experimental setup consisted of several pieces of equipment as described previously (<xref ref-type="bibr" rid="B1">Alsina et al., 2017</xref>; <xref ref-type="bibr" rid="B15">Chen et al., 2018</xref>). The shutter, stimulator, and camera were synchronized with a trigger from the camera through a Digidata 1550 (Molecular Devices, USA). Clampex (Molecular Devices) was used for generating electrical stimulation protocols. An IX-73 microscope (Olympus) with a 100X oil-immersion objective (UPlanSApo (Olympus)) was used. A 532-nm laser (OBIS 532 (Coherent Inc.)) with a dichroic mirror (ZT532rdc, Chroma) and emission filter (ET595/50m) was used to image FM 1-43-loaded synaptic vesicles. Normalized fluorescence of FM 1-43-loaded synaptic vesicles was calculated as the average fluorescence intensity in a region of interest (ROI) relative to the average fluorescence intensity in the same ROI during the first 20 s before electrical stimulation. The fluorescence intensity was measured with MetaMorph (Molecular Devices). Customer-made MATLAB (MathWorks Inc.) program was used to calculate the normalized fluorescence. Average normalized fluorescence was computed by averaging all normalized fluorescence from individual analyzed presynaptic terminals. Fluorescence loss of FM 1-43-loaded synaptic vesicles at single presynaptic terminals during stimulation was computed by subtracting the average normalized fluorescence in the final 60 s after stimulation from the average normalized fluorescence in first 20 s and was expressed as percentage. The destaining time constant of FM 1-43-loaded synaptic vesicles during stimulation was computed by fitting the data from 20 s through 140 s to a single exponential decay function using a custom-made MATLAB program. The fitting with R<sup>2</sup> &#x003E; 0.5 was used to compare destaining time constants between WT and HD striatal neurons. To perform imaging experiments of FM 4-64 loaded synaptic vesicles in VGLUT1-mCherry-expressing neurons in striatal culture, we transfected striatal neurons with a construct encoding VGLUT1-mCherry (a gift from Dr. Seok-Kyu Kwon at Korea Institute of Science and Technology (KIST)) at DIV9 using Lipofectamine 2000 (11668019, Thermo Fisher Scientific) as previously described (<xref ref-type="bibr" rid="B17">Dalby et al., 2004</xref>). Real-time imaging experiments and analyses of FM 4-64-loaded synaptic vesicles in VGLUT1-mCherry-expressing neurons in striatal culture were performed as described in the above.</p>
</sec>
<sec id="S2.SS5">
<title>Imaging of CypHer5E-labeled inhibitory synaptic vesicles</title>
<p>The imaging experiments of CypHer5E-labeled inhibitory synaptic vesicles were performed similarly to FM 1-43-loaded synaptic vesicles. CypHer5E-labeled antibodies against the luminal domain of vesicular GABA transporter (VGAT) (VGAT&#x2013;CypHer5E) were loaded into inhibitory synaptic vesicles in cultured striatal neurons by applying 1,200 field stimuli at 10 Hz for 120 s in the presence of 13 nM VGAT&#x2013;CypHer5E (131 103CpH (Synaptic System)) in a sample chamber at 37&#x00B0;C using a platinum electrode wired to a stimulator. The sample chamber was perfused for 10 min with ACSF solution. Fluorescence images of VGAT&#x2013;CypHer5E-labeled synaptic vesicles were obtained with ZT640rdc-UF1 (Chroma Technology) and an ET690/50M (Chroma Technology). A 640-nm laser (OBIS 640 (Coherent Inc.)) was used to excite VGAT&#x2013;CypHer5E. The stimulator was synchronized through Axon Digidata 1550 (Molecular Devices) and the EMCCD camera to trigger field stimulation at 10 Hz for 120 s. The analyses of CypHer5E-labeled synaptic vesicles were performed similarly as those of FM1-43-loaded synaptic vesicles. The fitting with R<sup>2</sup> &#x003E; 0.5 was used to compare exocytosis time constants of CypHer5E-labeled synaptic vesicles between WT and HD striatal neurons.</p>
</sec>
<sec id="S2.SS6">
<title>Analysis</title>
<p>The fluorescence intensities of FM 1-43-loaded and FM 4-64-loaded synaptic vesicles and VGAT-CypHer5E-labeled inhibitory synaptic vesicles within ROIs were measured with MetaMorph. Numerical data are presented as mean &#x00B1; <italic>standard error of the mean</italic> (SEM). The independent two-tailed Student&#x2019;s <italic>t</italic>-test and Mann&#x2013;Whitney U test were used to determine statistical differences between HD and WT neurons. A <italic>p-</italic>value lower than 0.05 (<italic>p</italic> &#x003C; 0.05) was considered as significant.</p>
</sec>
</sec>
<sec id="S3" sec-type="results">
<title>Results</title>
<sec id="S3.SS1">
<title>Medium spiny neurons (MSNs) were predominant in cultured striatal neurons</title>
<p>It was suggested that neurodegeneration in the striatum of HD is associated with abnormal synaptic transmission in striatal neurons (<xref ref-type="bibr" rid="B45">Milnerwood and Raymond, 2010</xref>; <xref ref-type="bibr" rid="B55">Raymond, 2016</xref>; <xref ref-type="bibr" rid="B67">Tyebji and Hannan, 2017</xref>; <xref ref-type="bibr" rid="B3">Barry et al., 2022</xref>; <xref ref-type="bibr" rid="B12">Cepeda and Levine, 2022</xref>). However, synaptic transmission in HD striatal neurons remains elusive. Particularly, exocytosis of synaptic vesicles at single presynaptic terminals in HD striatal neurons is poorly understood yet. To investigate whether exocytosis of synaptic vesicles is impaired at single presynaptic terminals in HD striatal neurons, we first cultured striatal neurons from zQ175 mice, which contain more than 180 CAG repeats and show the late onset and slow progression of HD symptoms (<xref ref-type="bibr" rid="B26">Heikkinen et al., 2012</xref>; <xref ref-type="bibr" rid="B42">Menalled et al., 2012</xref>).</p>
<p>First, we examined the identity of cultured WT and HD striatal neurons, which were isolated from striatal tissue of <italic>postnatal</italic> day 0 (P0) WT and heterozygous mice respectively and then were grown until mature synapses were formed. Mature striatal neurons were fixed and then immunostained with antibodies against microtubule-associated protein 2 (MAP2, a marker for neurons), glutamic acid decarboxylase 67 (GAD67, a marker for inhibitory neurons) and dopamine- and adenosine-3&#x2032;,5&#x2032;-monophosphate (cAMP)-regulated phosphoprotein of molecular weight 32 kDa (DARPP-32, a marker for MSNs). Representative confocal images of immunostained WT and HD striatal neurons co-stained with DAPI are shown in <xref ref-type="fig" rid="F1">Figure 1A</xref>. Colocalization analyses between MAP2 and GAD67 immunoreactivity revealed that cultured striatal neurons were predominately inhibitory (i.e., GAD67-positive) with no statistical difference between WT and HD neurons (86 &#x00B1; 2.5% (<italic>n</italic> = 39 images) versus 84 &#x00B1; 2.5% (<italic>n</italic> = 40), <italic>p</italic> = 0.62 from independent two-tailed Student&#x2019;s <italic>t</italic>-test) (<xref ref-type="fig" rid="F1">Figure 1B</xref>). To further examine the identity of these cultured striatal neurons, we analyzed immunoreactivity between GAD67 and DARPP-32. The analyses showed that inhibitory neurons in our cultured striatal neurons were predominantly MSNs with no statistical difference between WT and HD neurons (88 &#x00B1; 2.2% (<italic>n</italic> = 39) versus 92 &#x00B1; 2.0% (<italic>n</italic> = 40), <italic>p</italic> = 0.21 from independent two-tailed Student&#x2019;s <italic>t</italic>-test) (<xref ref-type="fig" rid="F1">Figure 1C</xref>). We also measured the percentage of excitatory neurons in our cultured striatal neurons using antibodies against vesicular glutamate transporter 1 (VGLUT1, a marker for excitatory neurons) and found that excitatory neurons were less than 10% of the neurons in the striatal cultures (9.5 &#x00B1; 0.44% (<italic>n</italic> = 38) versus 8.3 &#x00B1; 0.47% (<italic>n</italic> = 46), <italic>p</italic> = 0.058 from independent two-tailed Student&#x2019;s <italic>t</italic>-test) (<xref ref-type="supplementary-material" rid="FS1">Supplementary Figure 1</xref>). Thus, immunostaining results confirmed that our cultured striatal neurons were predominantly MSNs, which are known to be the principal neurons in the striatum (<xref ref-type="bibr" rid="B36">Kreitzer, 2009</xref>) and to undergo neurodegeneration in HD (<xref ref-type="bibr" rid="B69">Vonsattel and DiFiglia, 1998</xref>). Thus, our cultured striatal neurons were suitable for investigating the mechanisms of selective neurodegeneration in the striatum of HD.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption><p>Cultured striatal neurons were predominantly medium spiny neurons (MSNs). <bold>(A)</bold> Representative confocal images of WT and HD cultured striatal neurons immunostained for MAP2 (green), GAD67 (red), and DARPP32 (yellow). Nuclei were counterstained with DAPI (blue). WT and HD cultured striatal neurons were isolated from WT and heterozygous zQ175 mice and were grown on coverslips, respectively. The scale bars represent 20 &#x03BC;m. <bold>(B)</bold> Percentage of GAD67-positive cells in MAP2-positive cells, which represents the ratio of the inhibitory neurons in cultured striatal neurons. The percentage was not significantly different between WT and HD cultured striatal neurons (<italic>p</italic> = 0.62, independent two-tailed Student&#x2019;s <italic>t</italic>-test). <bold>(C)</bold> Percentage of DARPP32-positive cells in GAD67-positive cells, which represents the ratio of the MSNs. A high percentage of DARPP32-positive cells implies that cultured striatal neurons were predominantly MSNs. The percentage showed no significant difference between WT and HD striatal neurons (<italic>p</italic> = 0.21, independent two-tailed Student&#x2019;s <italic>t</italic>-test).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnmol-16-1175522-g001.tif"/>
</fig>
</sec>
<sec id="S3.SS2">
<title>Exocytosis of synaptic vesicles was altered at single presynaptic terminals of HD striatal neurons</title>
<p>Then, we examined whether exocytosis of synaptic vesicles is altered at presynaptic terminals of HD striatal neurons. Synaptic vesicles at presynaptic terminals of striatal neurons were loaded with FM 1-43 (a lipophilic styryl dye) using a train of 1,200 electrical field stimuli at 10 Hz for 120 s, which is widely used to label the total recycling pool (TRP) of synaptic vesicles (<xref ref-type="bibr" rid="B61">Ryan and Smith, 1995</xref>; <xref ref-type="bibr" rid="B74">Zhang et al., 2007</xref>; <xref ref-type="bibr" rid="B70">Welzel et al., 2011</xref>; <xref ref-type="bibr" rid="B38">Marra et al., 2012</xref>; <xref ref-type="bibr" rid="B52">Park et al., 2012</xref>, <xref ref-type="bibr" rid="B49">2021</xref>; <xref ref-type="bibr" rid="B15">Chen et al., 2018</xref>; <xref ref-type="bibr" rid="B54">Qin et al., 2019</xref>; <xref ref-type="bibr" rid="B13">Chen S. et al., 2021</xref>). After loading, we perfused ACSF solution to remove extracellular and plasma membrane-bound FM 1-43.</p>
<p>Representative fluorescence images of FM 1-43-loaded synaptic vesicles at presynaptic terminals of WT and HD cultured striatal neurons after extensive washing are shown in <xref ref-type="fig" rid="F2">Figures 2A, B</xref>. Fluorescence intensities of FM 1-43-loaded synaptic vesicles were measured within a fixed ROI (<xref ref-type="bibr" rid="B25">Harata et al., 2001</xref>; <xref ref-type="bibr" rid="B32">Jordan et al., 2005</xref>; <xref ref-type="bibr" rid="B15">Chen et al., 2018</xref>), which encircles a single isolated bright spot called a bouton. Single boutons are likely to represent single presynaptic terminals containing FM 1-43-loaded synaptic vesicles. Bouton density was estimated by counting boutons containing FM 1-43-loaded synaptic vesicles along axons. Bouton density in HD striatal neurons was significantly smaller than that in WT neurons (0.68 &#x00B1; 0.033 boutons/&#x03BC;m for HD neurons (<italic>N</italic> = 8 experiments) versus 0.83 &#x00B1; 0.034 boutons/&#x03BC;m for WT neurons (<italic>N</italic> = 6), <italic>p</italic> = 0.0012 from Mann&#x2013;Whitney U test)) (<xref ref-type="fig" rid="F2">Figure 2C</xref>), suggesting that the mutant huntingtin protein decreases the number of functional presynaptic terminals in HD striatal neurons.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption><p>Decreased bouton density in HD striatal neurons. <bold>(A)</bold> Representative image of synaptic vesicles loaded with FM 1-43 in WT striatal neurons. Red circles indicate ROIs representing presynaptic terminals, which were analyzed for exocytosis of FM 1-43. The scale bar represents 10 &#x03BC;m. <bold>(B)</bold> Representative image of synaptic vesicles loaded with FM 1-43 in HD striatal neurons. <bold>(C)</bold> Bouton density in WT (<italic>N</italic> = 6 experiments) and HD (<italic>N</italic> = 8) striatal neurons. &#x002A;&#x002A;<italic>p</italic> &#x003C; 0.01 (Mann&#x2013;Whitney U test).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnmol-16-1175522-g002.tif"/>
</fig>
<p>Next, we performed real-time imaging experiments of FM 1-43-loaded synaptic vesicles at single presynaptic terminals during 1,200 electrical stimuli to measure synaptic vesicle exocytosis. We analyzed fluorescence intensities of isolated boutons that showed destaining upon electrical field stimulation in order to exclude boutons that were labeled by spontaneous activity or non-specific binding (<xref ref-type="bibr" rid="B15">Chen et al., 2018</xref>). The decreased fluorescence intensity of FM 1-43 in each ROI after stimulation reflects exocytosis of FM 1-43-loaded synaptic vesicles at single presynaptic terminals. The normalized fluorescence intensity was calculated as the ratio of the fluorescence intensity of FM 1-43 in each ROI with respect to the baseline fluorescence intensity (the average intensity before stimulation) of FM 1-43 (<xref ref-type="bibr" rid="B15">Chen et al., 2018</xref>). <xref ref-type="fig" rid="F3">Figures 3A, B</xref> shows time courses of normalized fluorescence intensity at single presynaptic terminals in WT (<xref ref-type="fig" rid="F3">Figure 3A</xref>) and HD (<xref ref-type="fig" rid="F3">Figure 3B</xref>) striatal neurons during 1,200 electrical stimuli. As shown in <xref ref-type="fig" rid="F3">Figures 3A, B</xref>, 1,200 electrical stimuli induced rapid exocytosis of FM 1-43-loaded synaptic vesicles at single presynaptic terminals in both WT and HD striatal neurons. Individual time courses showed heterogeneous exocytosis at single presynaptic terminals. The amount of fluorescence loss at single presynaptic terminals in striatal neurons was highly varied and the coefficient of variation (CV) was 25% and 36% in WT and HD striatal neurons, respectively. However, fluorescence loss after 1,200 electrical stimuli was significantly lower in HD striatal neurons compared to WT striatal neurons (36 &#x00B1; 1.4% (<italic>n</italic> = 87 boutons, <italic>N</italic> = 15 experiments for HD) versus 47 &#x00B1; 1.2% (<italic>n</italic> = 90 boutons, <italic>N</italic> = 12 for WT), <italic>p</italic> = 1.4E-7 from Mann&#x2013;Whitney U test) (<xref ref-type="fig" rid="F3">Figure 3C</xref>). Considering that release probability is in proportion to the relative amount of exocytosed FM dyes (<xref ref-type="bibr" rid="B47">Murthy et al., 1997</xref>; <xref ref-type="bibr" rid="B8">Branco et al., 2008</xref>; <xref ref-type="bibr" rid="B7">Branco and Staras, 2009</xref>; <xref ref-type="bibr" rid="B18">Daniel et al., 2009</xref>), decreased fluorescence loss at single presynaptic terminals of HD striatal neurons suggests that the mutant huntingtin protein reduces the release probability of synaptic vesicles at single presynaptic terminals of HD striatal neurons. Furthermore, we measured the kinetics of synaptic vesicle exocytosis by fitting the time courses of fluorescence loss to a single exponential decay function (<xref ref-type="bibr" rid="B59">Richards et al., 2005</xref>; <xref ref-type="bibr" rid="B18">Daniel et al., 2009</xref>; <xref ref-type="bibr" rid="B15">Chen et al., 2018</xref>). <xref ref-type="fig" rid="F3">Figure 3D</xref> shows that the destaining time constant of FM 1-43 in HD was larger compared with WT neurons (56 &#x00B1; 4.8 s (<italic>n</italic> = 80 boutons) for HD versus 44 &#x00B1; 3.6 s (<italic>n</italic> = 87 boutons) for WT, <italic>p</italic> = 0.032 from Mann&#x2013;Whitney U test), implying slower destaining rate of synaptic vesicles at single presynaptic terminals of HD striatal neurons. Taken together, our results suggest that the mutant huntingtin protein decreases the number of functional presynaptic terminals and exocytosis at single presynaptic terminals of cultured striatal neurons of HD.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption><p>Exocytosis of synaptic vesicles in HD striatal neurons was altered. <bold>(A)</bold> Time courses of normalized fluorescence intensity of FM 1&#x2013;43-loaded synaptic vesicles during 1,200 electrical stimuli in WT striatal neurons (<italic>n</italic> = 90 boutons, <italic>N</italic> = 12 experiments). The thicker line represents the average normalized fluorescence. The blue line represents 1,200 electrical field stimuli applied at 10 Hz for 120 s. <bold>(B)</bold> Time courses of normalized fluorescence intensity of FM 1&#x2013;43-loaded synaptic vesicles during 1,200 electrical stimuli in HD striatal neurons (<italic>n</italic> = 87, <italic>N</italic> = 15). <bold>(C)</bold> Percentage of fluorescence loss of FM 1&#x2013;43-loaded synaptic vesicles in WT and HD striatal neurons. <bold>(D)</bold> Destaining time constant of FM 1&#x2013;43-loaded synaptic vesicles in WT and HD striatal neurons. &#x002A;<italic>p</italic> &#x003C; 0.05 and &#x002A;&#x002A;&#x002A;&#x002A;<italic>p</italic> &#x003C; 0.0001 (Mann&#x2013;Whitney U test).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnmol-16-1175522-g003.tif"/>
</fig>
</sec>
<sec id="S3.SS3">
<title>Exocytosis of inhibitory synaptic vesicles was altered in HD striatal neurons</title>
<p>Since our immunostaining results showed that the majority of our cultured striatal neurons were inhibitory neurons and exocytosis of synaptic vesicles at single presynaptic terminals of HD striatal neurons was altered, we further examined whether exocytosis of inhibitory synaptic vesicles is altered at single presynaptic terminals of HD striatal neurons. To measure exocytosis of inhibitory synaptic vesicles at single presynaptic terminals, we specifically labeled inhibitory synaptic vesicles with CypHer5E-labeled antibodies against the luminal domain of vesicular GABA transporter (VGAT&#x2013;CypHer5E) (<xref ref-type="bibr" rid="B15">Chen et al., 2018</xref>; <xref ref-type="bibr" rid="B49">Park et al., 2021</xref>) because CypHer5E shows maximum fluorescence at acidic pHs and drastic fluorescence decrease at neutral pHs (<xref ref-type="bibr" rid="B4">Beletskii et al., 2005</xref>; <xref ref-type="bibr" rid="B28">Hua et al., 2011</xref>). Similar to FM 1-43 staining, we stimulated neurons with 1,200 electrical stimuli to label inhibitory synaptic vesicles from the TRP with VGAT&#x2013;CypHer5E. <xref ref-type="fig" rid="F4">Figures 4A, B</xref> show representative fluorescence images of VGAT&#x2013;CypHer5E-labeled inhibitory synaptic vesicles at presynaptic terminals of WT (<xref ref-type="fig" rid="F4">Figure 4A</xref>) and HD striatal neurons (<xref ref-type="fig" rid="F4">Figure 4B</xref>). Inhibitory bouton density measured by VGAT&#x2013;CypHer5E-labeled synaptic vesicles in HD striatal neurons was smaller than that in WT neurons (0.59 &#x00B1; 0.028 boutons/&#x03BC;m for HD neurons (<italic>N</italic> = 8 experiments)) versus 0.70 &#x00B1; 0.030 boutons/&#x03BC;m for WT neurons (<italic>N</italic> = 6), <italic>p</italic> = 0.0063 from Mann&#x2013;Whitney U test) (<xref ref-type="fig" rid="F4">Figure 4C</xref>), suggesting that the mutant huntingtin protein decreases the number of functional inhibitory presynaptic terminals in HD striatal neurons.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption><p>HD striatal neurons exhibited reduced inhibitory bouton density. <bold>(A)</bold> Representative image of inhibitory synaptic vesicles labeled with VGAT-CypHer5E in WT striatal neurons. Red circles indicate ROIs representing inhibitory presynaptic terminals, which were analyzed for exocytosis of VGAT-CypHer5E. The scale bar represents 10 &#x03BC;m. <bold>(B)</bold> Representative image of inhibitory synaptic vesicles labeled with VGAT-CypHer5E in HD striatal neurons. <bold>(C)</bold> Inhibitory bouton density in WT (<italic>N</italic> = 6 experiments) and HD (<italic>N</italic> = 8) striatal neurons. &#x002A;&#x002A;<italic>p</italic> &#x003C; 0.01 (Mann&#x2013;Whitney U test).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnmol-16-1175522-g004.tif"/>
</fig>
<p>Next, we performed real-time imaging experiments of VGAT&#x2013;CypHer5E-labeled inhibitory synaptic vesicles at single presynaptic terminals during 1,200 electrical stimuli to measure exocytosis of inhibitory synaptic vesicles. Fluorescence intensities of boutons containing VGAT&#x2013;CypHer5E-labeled inhibitory synaptic vesicles drastically decreased upon electrical stimulation, reflecting exocytosis of VGAT&#x2013;CypHer5E-labeled inhibitory synaptic vesicles at single presynaptic terminals. The normalized fluorescence intensity of VGAT&#x2013;CypHer5E-labeled inhibitory synaptic vesicles was calculated using the same method as FM 1-43. <xref ref-type="fig" rid="F5">Figures 5A, B</xref> show time courses of normalized fluorescence intensity of VGAT&#x2013;CypHer5E-lableled inhibitory synaptic vesicles at single presynaptic terminals in WT (<xref ref-type="fig" rid="F5">Figure 5A</xref>) and HD (<xref ref-type="fig" rid="F5">Figure 5B</xref>) striatal neurons in a train of 1,200 electrical stimuli. 1,200 electrical stimuli induced rapid exocytosis of VGAT&#x2013;CypHer5E-labeled inhibitory synaptic vesicles at single presynaptic terminals in both WT and HD striatal neurons. Individual time courses of normalized fluorescence intensity showed heterogeneous exocytosis of VGAT&#x2013;CypHer5E-labeled inhibitory synaptic vesicles at single presynaptic terminals with CV values of 14% and 10% for WT and HD striatal neurons, respectively. Fluorescence loss after 1,200 electrical stimuli was significantly lower in HD striatal neurons compared to WT striatal neurons (67 &#x00B1; 1.1% (<italic>n</italic> = 41 boutons, <italic>N</italic> = 5 experiments for HD) versus 72 &#x00B1; 1.5% (<italic>n</italic> = 47 boutons, <italic>N</italic> = 5 for WT), <italic>p</italic> = 0.040 from Mann&#x2013;Whitney U test) (<xref ref-type="fig" rid="F5">Figure 5C</xref>). Considering the relationship between release probability and the relative amount of exocytosed VGAT&#x2013;CypHer5E, decreased fluorescence loss at presynaptic terminals of HD striatal neurons suggests that the mutant huntingtin protein decreases the release probability of inhibitory synaptic vesicles at single presynaptic terminals of HD striatal neurons. Furthermore, we measured the exocytosis rates of inhibitory synaptic vesicles by fitting the time courses of fluorescence loss to a single exponential decay function. <xref ref-type="fig" rid="F5">Figure 5D</xref> shows that the exocytosis time constant of VGAT&#x2013;CypHer5E-labeled synaptic vesicles in HD striatal neurons was significantly larger than WT neurons (54 &#x00B1; 4.2 s (<italic>n</italic> = 38 boutons) for HD versus 34 &#x00B1; 2.4 s (<italic>n</italic> = 49 boutons) for WT, <italic>p</italic> = 2.6E-4 from Mann&#x2013;Whitney U test), indicating slower exocytosis rate of inhibitory synaptic vesicles at single presynaptic terminals of HD striatal neurons. Given decreased density of functional inhibitory synapses and exocytosis at single presynaptic terminals of striatal neurons expressing the mutant huntingtin protein, we conclude that the mutant huntingtin protein alters inhibitory neurotransmission at single presynaptic terminals of HD striatal neurons. We also examined whether excitatory neurotransmission is altered in excitatory synapses of cultured striatal neurons by performing real-time imaging experiments of FM 4-64-loaded synaptic vesicles in VGLUT1-mCherry-expressing neurons in striatal cultures. We found no significant difference in bouton density, fluorescence loss and destaining time constant between WT and HD striatal neurons expressing VGLUT1-mCherry (<xref ref-type="supplementary-material" rid="FS1">Supplementary Figure 2</xref>), suggesting that exocytosis of excitatory synaptic vesicles may not be altered in HD striatal neurons expressing VGLUT1-mCherry.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption><p>Exocytosis of inhibitory synaptic vesicles in HD striatal neurons was altered. <bold>(A)</bold> Time courses of normalized fluorescence intensity of VGAT-CypHer5E-labeled inhibitory synaptic vesicles during 1,200 electrical field stimuli in WT striatal neurons (<italic>n</italic> = 47 boutons, <italic>N</italic> = 5 experiments). The thicker line represents average normalized fluorescence. The blue line represents 1,200 electrical field stimuli applied at 10 Hz for 120 s. <bold>(B)</bold> Time courses of normalized fluorescence intensity of VGAT-CypHer5E-labeled inhibitory synaptic vesicles during 1,200 electrical stimuli in HD striatal neurons (<italic>n</italic> = 41, <italic>N</italic> = 5). <bold>(C)</bold> Percentage of fluorescence loss of VGAT-CypHer5E-labeled inhibitory synaptic vesicles in WT and HD striatal neurons. <bold>(D)</bold> Exocytosis time constant of VGAT-CypHer5E-labeled inhibitory synaptic vesicles in WT and HD striatal neurons. &#x002A;<italic>p</italic> &#x003C; 0.05 and &#x002A;&#x002A;&#x002A;<italic>p</italic> &#x003C; 0.001 (Mann&#x2013;Whitney U test).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fnmol-16-1175522-g005.tif"/>
</fig>
</sec>
</sec>
<sec id="S4" sec-type="discussion">
<title>Discussion</title>
<p>Striatal neurons are the most vulnerable neurons in HD and undergo neurodegeneration in the disease progression of HD (<xref ref-type="bibr" rid="B69">Vonsattel and DiFiglia, 1998</xref>). However, the mechanisms of selective neurodegeneration of striatal neurons in HD remain elusive. Here, we used real-time imaging of FM 1-43-loaded synaptic vesicles during electrical field stimulation and showed a decrease in bouton density and exocytosis at single presynaptic terminals of cultured striatal neurons in zQ175 (a knock-in mouse model of HD) mice. Real-time imaging of VGAT-CypHer5E-labeled inhibitory synaptic vesicles revealed reduced inhibitory bouton density and exocytosis of inhibitory synaptic vesicles at single presynaptic terminals of striatal neurons from zQ175 mice. Our results suggest that the mutant huntingtin protein decreases functional inhibitory presynaptic terminals and exocytosis of inhibitory synaptic vesicles at single presynaptic terminals of striatal neurons, leading to impaired inhibitory synaptic transmission in the striatum of HD.</p>
<p>Our findings about the decrease in exocytosis of inhibitory synaptic vesicles at single presynaptic terminals in cultured striatal neurons of zQ175 mice are consistent with recent whole-cell patch clamp results showing decreased current in inhibitory evoked synaptic responses with the decreased readily releasable pool (RRP) in autaptic striatal neurons infected with lentiviruses expressing human huntingtin exon 1 with expanded CAG repeats (97Q-Htt) (<xref ref-type="bibr" rid="B48">Paraskevopoulou et al., 2021</xref>). Moreover, our results fit with other papers reporting decreased concentration of GABA in the striatum in several HD mouse models and HD patients (<xref ref-type="bibr" rid="B53">Perry et al., 1973</xref>; <xref ref-type="bibr" rid="B66">Spokes et al., 1980</xref>; <xref ref-type="bibr" rid="B71">W&#x00F3;jtowicz et al., 2013</xref>; <xref ref-type="bibr" rid="B63">Serranilla and Woodin, 2021</xref>). Recently, real-time imaging of Synaptophysin-pHluorin showed altered endocytosis of synaptic vesicles during high frequency (40Hz) stimulation in cultured striatal neurons from another knock-in HD mouse model (Q140 mice) (<xref ref-type="bibr" rid="B40">McAdam et al., 2020</xref>). These altered exocytosis and endocytosis of synaptic vesicles in striatal neurons of HD might disrupt synaptic transmission in the striatum of HD (<xref ref-type="bibr" rid="B12">Cepeda and Levine, 2022</xref>) because exocytosis and endocytosis of synaptic vesicles mediates synaptic transmission (<xref ref-type="bibr" rid="B46">Mochida, 2022</xref>; <xref ref-type="bibr" rid="B50">Park et al., 2022</xref>). Disrupted synaptic transmission may weaken synaptic connection, which was observed as decreased bouton density in our cultured HD striatal neurons and as decreased spine density in the MSNs in the striatum of symptomatic R6/2 (<xref ref-type="bibr" rid="B10">Cepeda et al., 2013</xref>) and zQ175 mice (<xref ref-type="bibr" rid="B30">Indersmitten et al., 2015</xref>). Weakened synaptic connection in the striatal circuit could cause abnormal movements in HD patients.</p>
<p>Neurons in the striatum receive excitatory inputs from the cortex and the thalamus through corticostriatal and thalamostriatal synapses (<xref ref-type="bibr" rid="B20">Ding et al., 2008</xref>; <xref ref-type="bibr" rid="B29">Hunnicutt et al., 2016</xref>; <xref ref-type="bibr" rid="B57">Reiner and Deng, 2018</xref>). Destaining experiments of FM dyes demonstrated an increase in exocytosis of synaptic vesicles in cultured cortical neurons (<xref ref-type="bibr" rid="B15">Chen et al., 2018</xref>) and brain slices of young HD mice (<xref ref-type="bibr" rid="B33">Joshi et al., 2009</xref>). Electrophysiology measurements suggested increased release probability of synaptic vesicles from presynaptic terminals of HD thalamic neurons (<xref ref-type="bibr" rid="B35">Kolodziejczyk and Raymond, 2016</xref>). Increased release of excitatory neurotransmitters through corticostriatal and thalamostriatal synapses can play a detrimental role in HD striatal neurons. Moreover, real-time imaging of BDNF-pHluorin revealed deceased release of BDNF in cultured cortical neurons of HD mice (<xref ref-type="bibr" rid="B72">Yu et al., 2018</xref>). These increased release of excitatory neurotransmitters from cortical and thalamic neurons, decreased release of BDNF from cortical neurons, and decreased release of inhibitory neurotransmitters in striatal neurons may contribute to neurodegeneration in the striatum of HD.</p>
<p>Mechanisms underlying these decreased functional presynaptic density and exocytosis of inhibitory synaptic vesicles at single presynaptic terminals of striatal neurons expressing the mutant huntingtin protein remain to be elucidated. Recent RNA sequencing of striatal neurons containing the mutant huntingtin protein revealed differentially expressed genes (<xref ref-type="bibr" rid="B48">Paraskevopoulou et al., 2021</xref>; <xref ref-type="bibr" rid="B39">Matsushima et al., 2023</xref>), which provides possible clues to molecular mechanisms for altered synaptic transmission in HD. Furthermore, the application of single synaptic vesicle tracking methods (<xref ref-type="bibr" rid="B52">Park et al., 2012</xref>, <xref ref-type="bibr" rid="B50">2022</xref>; <xref ref-type="bibr" rid="B31">Joensuu et al., 2016</xref>; <xref ref-type="bibr" rid="B73">Yu et al., 2016</xref>; <xref ref-type="bibr" rid="B14">Chen X. et al., 2021</xref>) could help to elucidate whether altered exocytosis of synaptic vesicles is caused by the dynamics of single inhibitory synaptic vesicles in HD striatal neurons.</p>
<p>In summary, we report decreased functional inhibitory presynaptic density and exocytosis of inhibitory synaptic vesicles at single presynaptic terminals during electrical field stimulation in cultured striatal neurons obtained from zQ175 HD mice. Our findings suggest that the mutant huntingtin protein decreases exocytosis of inhibitory synaptic vesicles at single presynaptic terminals of striatal neurons, impairing inhibitory synaptic transmission, eventually leading to neurodegeneration in the striatum of HD. Thus, our work provide a new insight into selective neurodegeneration of vulnerable neurons in HD.</p>
</sec>
<sec id="S5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="S6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The animal study was reviewed and approved by Hong Kong University of Science and Technology.</p>
</sec>
<sec id="S7" sec-type="author-contributions">
<title>Author contributions</title>
<p>CX, SC, XC, and HP designed the experiments and wrote the manuscript. CX, SC, XC, KH, and HY performed the experiments. CX, SC, XC, KH, and CP analyzed the data. SC provided the analysis programs. CX, SC, XC, S-HL, and HP interpreted the results. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<sec id="S8" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by the Research Grants Council of Hong Kong (Grants 16102322 and <italic>N</italic>_HKUST613/17) and the Innovation and Technology Commission (ITCPD/17-9). CP was supported by Hong Kong Center for Construction Robotics (InnoHK-HKCRC: InnoHK center supported by Hong Kong ITC).</p>
</sec>
<ack><p>We thank members of Park lab for helpful discussion and comments.</p>
</ack>
<sec id="S9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor SJ declared a past co-authorship with the authors SC, XC, CP, HY, and HP.</p>
</sec>
<sec id="S10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="S11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fnmol.2023.1175522/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fnmol.2023.1175522/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Presentation_1.pdf" id="FS1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alsina</surname> <given-names>A.</given-names></name> <name><surname>Lai</surname> <given-names>W. M.</given-names></name> <name><surname>Wong</surname> <given-names>W. K.</given-names></name> <name><surname>Qin</surname> <given-names>X.</given-names></name> <name><surname>Zhang</surname> <given-names>M.</given-names></name> <name><surname>Park</surname> <given-names>H.</given-names></name></person-group> (<year>2017</year>). <article-title>Real-time subpixel-accuracy tracking of single mitochondria in neurons reveals heterogeneous mitochondrial motion.</article-title> <source><italic>Biochem. Biophys. Res. Commun.</italic></source> <volume>493</volume> <fpage>776</fpage>&#x2013;<lpage>782</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2017.08.103</pub-id> <pub-id pub-id-type="pmid">28882593</pub-id></citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barron</surname> <given-names>J. C.</given-names></name> <name><surname>Hurley</surname> <given-names>E. P.</given-names></name> <name><surname>Parsons</surname> <given-names>M. P.</given-names></name></person-group> (<year>2021</year>). <article-title>Huntingtin and the synapse.</article-title> <source><italic>Front. Cell. Neurosci.</italic></source> <volume>15</volume>:<issue>689332</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2021.689332</pub-id> <pub-id pub-id-type="pmid">34211373</pub-id></citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barry</surname> <given-names>J.</given-names></name> <name><surname>Bui</surname> <given-names>M. T. N.</given-names></name> <name><surname>Levine</surname> <given-names>M. S.</given-names></name> <name><surname>Cepeda</surname> <given-names>C.</given-names></name></person-group> (<year>2022</year>). <article-title>Synaptic pathology in Huntington&#x2019;s disease: Beyond the corticostriatal pathway.</article-title> <source><italic>Neurobiol. Dis.</italic></source> <volume>162</volume>:<issue>105574</issue>.</citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beletskii</surname> <given-names>A.</given-names></name> <name><surname>Cooper</surname> <given-names>M.</given-names></name> <name><surname>Sriraman</surname> <given-names>P.</given-names></name> <name><surname>Chiriac</surname> <given-names>C.</given-names></name> <name><surname>Zhao</surname> <given-names>L.</given-names></name> <name><surname>Abbot</surname> <given-names>S.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>High-throughput phagocytosis assay utilizing a pH-sensitive fluorescent dye.</article-title> <source><italic>Biotechniques</italic></source> <volume>39</volume> <fpage>894</fpage>&#x2013;<lpage>897</lpage>. <pub-id pub-id-type="doi">10.2144/000112001</pub-id> <pub-id pub-id-type="pmid">16382909</pub-id></citation></ref>
<ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bezprozvanny</surname> <given-names>I.</given-names></name></person-group> (<year>2009</year>). <article-title>Calcium signaling and neurodegenerative diseases.</article-title> <source><italic>Trends Mol. Med.</italic></source> <volume>15</volume> <fpage>89</fpage>&#x2013;<lpage>100</lpage>.</citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Botelho</surname> <given-names>E. P.</given-names></name> <name><surname>Wang</surname> <given-names>E.</given-names></name> <name><surname>Chen</surname> <given-names>J. Y.</given-names></name> <name><surname>Holley</surname> <given-names>S.</given-names></name> <name><surname>Andre</surname> <given-names>V.</given-names></name> <name><surname>Cepeda</surname> <given-names>C.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Differential synaptic and extrasynaptic glutamate-receptor alterations in striatal medium-sized spiny neurons of aged YAC128 Huntington&#x2019;s disease mice.</article-title> <source><italic>PLoS Curr.</italic></source> <volume>9</volume>:<issue>ecurrents.hd.2f36af340a70a0d248b48d4cc9c3e58e</issue>. <pub-id pub-id-type="doi">10.1371/currents.hd.2f36af340a70a0d248b48d4cc9c3e58e</pub-id> <pub-id pub-id-type="pmid">28856061</pub-id></citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Branco</surname> <given-names>T.</given-names></name> <name><surname>Staras</surname> <given-names>K.</given-names></name></person-group> (<year>2009</year>). <article-title>The probability of neurotransmitter release: Variability and feedback control at single synapses.</article-title> <source><italic>Neuroscience</italic></source> <volume>10</volume> <fpage>373</fpage>&#x2013;<lpage>383</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2634</pub-id> <pub-id pub-id-type="pmid">19377502</pub-id></citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Branco</surname> <given-names>T.</given-names></name> <name><surname>Staras</surname> <given-names>K.</given-names></name> <name><surname>Darcy</surname> <given-names>K. J.</given-names></name> <name><surname>Goda</surname> <given-names>Y.</given-names></name></person-group> (<year>2008</year>). <article-title>Local dendritic activity sets release probability at hippocampal synapses.</article-title> <source><italic>Neuron</italic></source> <volume>59</volume> <fpage>475</fpage>&#x2013;<lpage>485</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2008.07.006</pub-id> <pub-id pub-id-type="pmid">18701072</pub-id></citation></ref>
<ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carmo</surname> <given-names>C.</given-names></name> <name><surname>Naia</surname> <given-names>L.</given-names></name> <name><surname>Lopes</surname> <given-names>C.</given-names></name> <name><surname>Rego</surname> <given-names>A. C.</given-names></name></person-group> (<year>2018</year>). <article-title>Mitochondrial dysfunction in Huntington&#x2019;s disease.</article-title> <source><italic>Adv. Exp. Med. Biol.</italic></source> <volume>1049</volume> <fpage>59</fpage>&#x2013;<lpage>83</lpage>.</citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cepeda</surname> <given-names>C.</given-names></name> <name><surname>Galvan</surname> <given-names>L.</given-names></name> <name><surname>Holley</surname> <given-names>S. M.</given-names></name> <name><surname>Rao</surname> <given-names>S. P.</given-names></name> <name><surname>Andre</surname> <given-names>V. M.</given-names></name> <name><surname>Botelho</surname> <given-names>E. P.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Multiple sources of striatal inhibition are differentially affected in Huntington&#x2019;s disease mouse models.</article-title> <source><italic>J. Neurosci.</italic></source> <volume>33</volume> <fpage>7393</fpage>&#x2013;<lpage>7406</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2137-12.2013</pub-id> <pub-id pub-id-type="pmid">23616545</pub-id></citation></ref>
<ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cepeda</surname> <given-names>C.</given-names></name> <name><surname>Hurst</surname> <given-names>R. S.</given-names></name> <name><surname>Calvert</surname> <given-names>C. R.</given-names></name> <name><surname>Hernandez-Echeagaray</surname> <given-names>E.</given-names></name> <name><surname>Nguyen</surname> <given-names>O. K.</given-names></name> <name><surname>Jocoy</surname> <given-names>E.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington&#x2019;s disease.</article-title> <source><italic>J. Neurosci.</italic></source> <volume>23</volume> <fpage>961</fpage>&#x2013;<lpage>969</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-03-00961.2003</pub-id> <pub-id pub-id-type="pmid">12574425</pub-id></citation></ref>
<ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cepeda</surname> <given-names>C.</given-names></name> <name><surname>Levine</surname> <given-names>M. S.</given-names></name></person-group> (<year>2022</year>). <article-title>Synaptic dysfunction in Huntington&#x2019;s disease: Lessons from genetic animal models.</article-title> <source><italic>Neuroscientist</italic></source> <volume>28</volume> <fpage>20</fpage>&#x2013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1177/1073858420972662</pub-id> <pub-id pub-id-type="pmid">33198566</pub-id></citation></ref>
<ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>S.</given-names></name> <name><surname>Yoo</surname> <given-names>H.</given-names></name> <name><surname>Li</surname> <given-names>C. H.</given-names></name> <name><surname>Park</surname> <given-names>C.</given-names></name> <name><surname>Park</surname> <given-names>G.</given-names></name> <name><surname>Tan</surname> <given-names>L. Y.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Real-time three-dimensional tracking of single vesicles reveals abnormal motion and pools of synaptic vesicles in neurons of Huntington&#x2019;s disease mice.</article-title> <source><italic>iScience</italic></source> <volume>24</volume>:<issue>103181</issue>. <pub-id pub-id-type="doi">10.1016/j.isci.2021.103181</pub-id> <pub-id pub-id-type="pmid">34703988</pub-id></citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>X.</given-names></name> <name><surname>Liu</surname> <given-names>T.</given-names></name> <name><surname>Qin</surname> <given-names>X.</given-names></name> <name><surname>Nguyen</surname> <given-names>Q. Q.</given-names></name> <name><surname>Lee</surname> <given-names>S. K.</given-names></name> <name><surname>Lee</surname> <given-names>C.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Simultaneous real-time three-dimensional localization and FRET measurement of two distinct particles.</article-title> <source><italic>Nano Lett.</italic></source> <volume>21</volume> <fpage>7479</fpage>&#x2013;<lpage>7485</lpage>. <pub-id pub-id-type="doi">10.1021/acs.nanolett.1c01328</pub-id> <pub-id pub-id-type="pmid">34491760</pub-id></citation></ref>
<ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>S.</given-names></name> <name><surname>Yu</surname> <given-names>C.</given-names></name> <name><surname>Rong</surname> <given-names>L.</given-names></name> <name><surname>Li</surname> <given-names>C. H.</given-names></name> <name><surname>Qin</surname> <given-names>X.</given-names></name> <name><surname>Ryu</surname> <given-names>H.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Altered synaptic vesicle release and Ca(<sup>2+</sup>) influx at single presynaptic terminals of cortical neurons in a knock-in mouse model of Huntington&#x2019;s disease.</article-title> <source><italic>Front. Mol. Neurosci.</italic></source> <volume>11</volume>:<issue>478</issue>. <pub-id pub-id-type="doi">10.3389/fnmol.2018.00478</pub-id> <pub-id pub-id-type="pmid">30618623</pub-id></citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cummings</surname> <given-names>D. M.</given-names></name> <name><surname>Cepeda</surname> <given-names>C.</given-names></name> <name><surname>Levine</surname> <given-names>M. S.</given-names></name></person-group> (<year>2010</year>). <article-title>Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington&#x2019;s disease.</article-title> <source><italic>ASN Neuro</italic></source> <volume>2</volume>:<issue>e00036</issue>. <pub-id pub-id-type="doi">10.1042/AN20100007</pub-id> <pub-id pub-id-type="pmid">20585470</pub-id></citation></ref>
<ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dalby</surname> <given-names>B.</given-names></name> <name><surname>Cates</surname> <given-names>S.</given-names></name> <name><surname>Harris</surname> <given-names>A.</given-names></name> <name><surname>Ohki</surname> <given-names>E. C.</given-names></name> <name><surname>Tilkins</surname> <given-names>M. L.</given-names></name> <name><surname>Price</surname> <given-names>P. J.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Advanced transfection with Lipofectamine 2000 reagent: Primary neurons, siRNA, and high-throughput applications.</article-title> <source><italic>Methods</italic></source> <volume>33</volume> <fpage>95</fpage>&#x2013;<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymeth.2003.11.023</pub-id> <pub-id pub-id-type="pmid">15121163</pub-id></citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Daniel</surname> <given-names>J. A.</given-names></name> <name><surname>Galbraith</surname> <given-names>S.</given-names></name> <name><surname>Iacovitti</surname> <given-names>L.</given-names></name> <name><surname>Abdipranoto</surname> <given-names>A.</given-names></name> <name><surname>Vissel</surname> <given-names>B.</given-names></name></person-group> (<year>2009</year>). <article-title>Functional heterogeneity at dopamine release sites.</article-title> <source><italic>J. Neurosci.</italic></source> <volume>29</volume> <fpage>14670</fpage>&#x2013;<lpage>14680</lpage>.</citation></ref>
<ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dayalu</surname> <given-names>P.</given-names></name> <name><surname>Albin</surname> <given-names>R. L.</given-names></name></person-group> (<year>2015</year>). <article-title>Huntington disease: Pathogenesis and treatment.</article-title> <source><italic>Neurol. Clin.</italic></source> <volume>33</volume> <fpage>101</fpage>&#x2013;<lpage>114</lpage>.</citation></ref>
<ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname> <given-names>J.</given-names></name> <name><surname>Peterson</surname> <given-names>J. D.</given-names></name> <name><surname>Surmeier</surname> <given-names>D. J.</given-names></name></person-group> (<year>2008</year>). <article-title>Corticostriatal and thalamostriatal synapses have distinctive properties.</article-title> <source><italic>J. Neurosci.</italic></source> <volume>28</volume> <fpage>6483</fpage>&#x2013;<lpage>6492</lpage>.</citation></ref>
<ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Du</surname> <given-names>Z.</given-names></name> <name><surname>Tertrais</surname> <given-names>M.</given-names></name> <name><surname>Courtand</surname> <given-names>G.</given-names></name> <name><surname>Leste-Lasserre</surname> <given-names>T.</given-names></name> <name><surname>Cardoit</surname> <given-names>L.</given-names></name> <name><surname>Masmejean</surname> <given-names>F.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Differential alteration in expression of striatal GABA(A)R subunits in mouse models of Huntington&#x2019;s disease.</article-title> <source><italic>Front. Mol. Neurosci.</italic></source> <volume>10</volume>:<issue>198</issue>. <pub-id pub-id-type="doi">10.3389/fnmol.2017.00198</pub-id> <pub-id pub-id-type="pmid">28676743</pub-id></citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Franco-Iborra</surname> <given-names>S.</given-names></name> <name><surname>Vila</surname> <given-names>M.</given-names></name> <name><surname>Perier</surname> <given-names>C.</given-names></name></person-group> (<year>2018</year>). <article-title>Mitochondrial quality control in neurodegenerative diseases: Focus on Parkinson&#x2019;s disease and Huntington&#x2019;s disease.</article-title> <source><italic>Front. Neurosci.</italic></source> <volume>12</volume>:<issue>342</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2018.00342</pub-id> <pub-id pub-id-type="pmid">29875626</pub-id></citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garret</surname> <given-names>M.</given-names></name> <name><surname>Du</surname> <given-names>Z.</given-names></name> <name><surname>Chazalon</surname> <given-names>M.</given-names></name> <name><surname>Cho</surname> <given-names>Y. H.</given-names></name> <name><surname>Baufreton</surname> <given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>Alteration of GABAergic neurotransmission in Huntington&#x2019;s disease.</article-title> <source><italic>CNS Neurosci. Ther.</italic></source> <volume>24</volume> <fpage>292</fpage>&#x2013;<lpage>300</lpage>.</citation></ref>
<ref id="B24"><citation citation-type="journal"><collab>The Huntington&#x2019;s Disease Collaborative Research Group</collab> (<year>1993</year>). <article-title>A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington&#x2019;s disease chromosomes. The Huntington&#x2019;s disease collaborative research group.</article-title> <source><italic>Cell</italic></source> <volume>72</volume> <fpage>971</fpage>&#x2013;<lpage>983</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(93)90585-e</pub-id> <pub-id pub-id-type="pmid">8458085</pub-id></citation></ref>
<ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harata</surname> <given-names>N.</given-names></name> <name><surname>Ryan</surname> <given-names>T. A.</given-names></name> <name><surname>Smith</surname> <given-names>S. J.</given-names></name> <name><surname>Buchanan</surname> <given-names>J.</given-names></name> <name><surname>Tsien</surname> <given-names>R. W.</given-names></name></person-group> (<year>2001</year>). <article-title>Visualizing recycling synaptic vesicles in hippocampal neurons by FM 1-43 photoconversion.</article-title> <source><italic>PNAS</italic></source> <volume>98</volume> <fpage>12748</fpage>&#x2013;<lpage>12753</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.171442798</pub-id> <pub-id pub-id-type="pmid">11675506</pub-id></citation></ref>
<ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heikkinen</surname> <given-names>T.</given-names></name> <name><surname>Lehtimaki</surname> <given-names>K.</given-names></name> <name><surname>Vartiainen</surname> <given-names>N.</given-names></name> <name><surname>Puolivali</surname> <given-names>J.</given-names></name> <name><surname>Hendricks</surname> <given-names>S. J.</given-names></name> <name><surname>Glaser</surname> <given-names>J. R.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington&#x2019;s disease.</article-title> <source><italic>PLoS One</italic></source> <volume>7</volume>:<issue>e50717</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0050717</pub-id> <pub-id pub-id-type="pmid">23284644</pub-id></citation></ref>
<ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname> <given-names>Y. T.</given-names></name> <name><surname>Chang</surname> <given-names>Y. G.</given-names></name> <name><surname>Chern</surname> <given-names>Y.</given-names></name></person-group> (<year>2018</year>). <article-title>Insights into GABA(A)ergic system alteration in Huntington&#x2019;s disease.</article-title> <source><italic>Open Biol.</italic></source> <volume>8</volume>:<issue>180165</issue>. <pub-id pub-id-type="doi">10.1098/rsob.180165</pub-id> <pub-id pub-id-type="pmid">30518638</pub-id></citation></ref>
<ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hua</surname> <given-names>Y.</given-names></name> <name><surname>Sinha</surname> <given-names>R.</given-names></name> <name><surname>Thiel</surname> <given-names>C. S.</given-names></name> <name><surname>Schmidt</surname> <given-names>R.</given-names></name> <name><surname>H&#x00FC;ve</surname> <given-names>J.</given-names></name> <name><surname>Martens</surname> <given-names>H.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>A readily retrievable pool of synaptic vesicles.</article-title> <source><italic>Nat. Neurosci.</italic></source> <volume>14</volume> <fpage>833</fpage>&#x2013;<lpage>839</lpage>.</citation></ref>
<ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hunnicutt</surname> <given-names>B. J.</given-names></name> <name><surname>Jongbloets</surname> <given-names>B. C.</given-names></name> <name><surname>Birdsong</surname> <given-names>W. T.</given-names></name> <name><surname>Gertz</surname> <given-names>K. J.</given-names></name> <name><surname>Zhong</surname> <given-names>H.</given-names></name> <name><surname>Mao</surname> <given-names>T.</given-names></name></person-group> (<year>2016</year>). <article-title>A comprehensive excitatory input map of the striatum reveals novel functional organization.</article-title> <source><italic>eLife</italic></source> <volume>5</volume>:<issue>e19103</issue>. <pub-id pub-id-type="doi">10.7554/eLife.19103</pub-id> <pub-id pub-id-type="pmid">27892854</pub-id></citation></ref>
<ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Indersmitten</surname> <given-names>T.</given-names></name> <name><surname>Tran</surname> <given-names>C. H.</given-names></name> <name><surname>Cepeda</surname> <given-names>C.</given-names></name> <name><surname>Levine</surname> <given-names>M. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Altered excitatory and inhibitory inputs to striatal medium-sized spiny neurons and cortical pyramidal neurons in the Q175 mouse model of Huntington&#x2019;s disease.</article-title> <source><italic>J. Neurophysiol.</italic></source> <volume>113</volume> <fpage>2953</fpage>&#x2013;<lpage>2966</lpage>. <pub-id pub-id-type="doi">10.1152/jn.01056.2014</pub-id> <pub-id pub-id-type="pmid">25673747</pub-id></citation></ref>
<ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Joensuu</surname> <given-names>M.</given-names></name> <name><surname>Padmanabhan</surname> <given-names>P.</given-names></name> <name><surname>Durisic</surname> <given-names>N.</given-names></name> <name><surname>Bademosi</surname> <given-names>A. T.</given-names></name> <name><surname>Cooper-Williams</surname> <given-names>E.</given-names></name> <name><surname>Morrow</surname> <given-names>I. C.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Subdiffractional tracking of internalized molecules reveals heterogeneous motion states of synaptic vesicles.</article-title> <source><italic>J. Cell Biol.</italic></source> <volume>215</volume> <fpage>277</fpage>&#x2013;<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201604001</pub-id> <pub-id pub-id-type="pmid">27810917</pub-id></citation></ref>
<ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jordan</surname> <given-names>R.</given-names></name> <name><surname>Lemke</surname> <given-names>E. A.</given-names></name> <name><surname>Klingauf</surname> <given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title>Visualization of synaptic vesicle movement in intact synaptic boutons using fluorescence fluctuation spectroscopy.</article-title> <source><italic>Biophys. J.</italic></source> <volume>89</volume> <fpage>2091</fpage>&#x2013;<lpage>2102</lpage>. <pub-id pub-id-type="doi">10.1529/biophysj.105.061663</pub-id> <pub-id pub-id-type="pmid">15980175</pub-id></citation></ref>
<ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Joshi</surname> <given-names>P. R.</given-names></name> <name><surname>Wu</surname> <given-names>N. P.</given-names></name> <name><surname>Andre</surname> <given-names>V. M.</given-names></name> <name><surname>Cummings</surname> <given-names>D. M.</given-names></name> <name><surname>Cepeda</surname> <given-names>C.</given-names></name> <name><surname>Joyce</surname> <given-names>J. A.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease.</article-title> <source><italic>J. Neurosci.</italic></source> <volume>29</volume> <fpage>2414</fpage>&#x2013;<lpage>2427</lpage>.</citation></ref>
<ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klapstein</surname> <given-names>G. J.</given-names></name> <name><surname>Fisher</surname> <given-names>R. S.</given-names></name> <name><surname>Zanjani</surname> <given-names>H.</given-names></name> <name><surname>Cepeda</surname> <given-names>C.</given-names></name> <name><surname>Jokel</surname> <given-names>E. S.</given-names></name> <name><surname>Chesselet</surname> <given-names>M. F.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington&#x2019;s disease transgenic mice.</article-title> <source><italic>J. Neurophysiol.</italic></source> <volume>86</volume> <fpage>2667</fpage>&#x2013;<lpage>2677</lpage>.</citation></ref>
<ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kolodziejczyk</surname> <given-names>K.</given-names></name> <name><surname>Raymond</surname> <given-names>L. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Differential changes in thalamic and cortical excitatory synapses onto striatal spiny projection neurons in a Huntington disease mouse model.</article-title> <source><italic>Neurobiol. Dis.</italic></source> <volume>86</volume> <fpage>62</fpage>&#x2013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2015.11.020</pub-id> <pub-id pub-id-type="pmid">26621114</pub-id></citation></ref>
<ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kreitzer</surname> <given-names>A. C.</given-names></name></person-group> (<year>2009</year>). <article-title>Physiology and pharmacology of striatal neurons.</article-title> <source><italic>Annu. Rev. Neurosci.</italic></source> <volume>32</volume> <fpage>127</fpage>&#x2013;<lpage>147</lpage>.</citation></ref>
<ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>J. Y.</given-names></name> <name><surname>Plomann</surname> <given-names>M.</given-names></name> <name><surname>Brundin</surname> <given-names>P.</given-names></name></person-group> (<year>2003</year>). <article-title>Huntington&#x2019;s disease: A synaptopathy?</article-title> <source><italic>Trends Mol. Med.</italic></source> <volume>9</volume> <fpage>414</fpage>&#x2013;<lpage>420</lpage>.</citation></ref>
<ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marra</surname> <given-names>V.</given-names></name> <name><surname>Burden</surname> <given-names>J. J.</given-names></name> <name><surname>Thorpe</surname> <given-names>J. R.</given-names></name> <name><surname>Smith</surname> <given-names>I. T.</given-names></name> <name><surname>Smith</surname> <given-names>S. L.</given-names></name> <name><surname>Hausser</surname> <given-names>M.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>A preferentially segregated recycling vesicle pool of limited size supports neurotransmission in native central synapses.</article-title> <source><italic>Neuron</italic></source> <volume>76</volume> <fpage>579</fpage>&#x2013;<lpage>589</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.08.042</pub-id> <pub-id pub-id-type="pmid">23141069</pub-id></citation></ref>
<ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsushima</surname> <given-names>A.</given-names></name> <name><surname>Pineda</surname> <given-names>S. S.</given-names></name> <name><surname>Crittenden</surname> <given-names>J. R.</given-names></name> <name><surname>Lee</surname> <given-names>H.</given-names></name> <name><surname>Galani</surname> <given-names>K.</given-names></name> <name><surname>Mantero</surname> <given-names>J.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Transcriptional vulnerabilities of striatal neurons in human and rodent models of Huntington&#x2019;s disease.</article-title> <source><italic>Nat. Commun.</italic></source> <volume>14</volume>:<issue>282</issue>.</citation></ref>
<ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McAdam</surname> <given-names>R. L.</given-names></name> <name><surname>Morton</surname> <given-names>A.</given-names></name> <name><surname>Gordon</surname> <given-names>S. L.</given-names></name> <name><surname>Alterman</surname> <given-names>J. F.</given-names></name> <name><surname>Khvorova</surname> <given-names>A.</given-names></name> <name><surname>Cousin</surname> <given-names>M. A.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Loss of huntingtin function slows synaptic vesicle endocytosis in striatal neurons from the htt(Q140/Q140) mouse model of Huntington&#x2019;s disease.</article-title> <source><italic>Neurobiol. Dis.</italic></source> <volume>134</volume>:<issue>104637</issue>. <pub-id pub-id-type="doi">10.1016/j.nbd.2019.104637</pub-id> <pub-id pub-id-type="pmid">31614197</pub-id></citation></ref>
<ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McColgan</surname> <given-names>P.</given-names></name> <name><surname>Tabrizi</surname> <given-names>S. J.</given-names></name></person-group> (<year>2018</year>). <article-title>Huntington&#x2019;s disease: A clinical review.</article-title> <source><italic>Eur. J. Neurol.</italic></source> <volume>25</volume> <fpage>24</fpage>&#x2013;<lpage>34</lpage>.</citation></ref>
<ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Menalled</surname> <given-names>L. B.</given-names></name> <name><surname>Kudwa</surname> <given-names>A. E.</given-names></name> <name><surname>Miller</surname> <given-names>S.</given-names></name> <name><surname>Fitzpatrick</surname> <given-names>J.</given-names></name> <name><surname>Watson-Johnson</surname> <given-names>J.</given-names></name> <name><surname>Keating</surname> <given-names>N.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington&#x2019;s disease: ZQ175.</article-title> <source><italic>PLoS One</italic></source> <volume>7</volume>:<issue>e49838</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0049838</pub-id> <pub-id pub-id-type="pmid">23284626</pub-id></citation></ref>
<ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname> <given-names>B. R.</given-names></name> <name><surname>Bezprozvanny</surname> <given-names>I.</given-names></name></person-group> (<year>2010</year>). <article-title>Corticostriatal circuit dysfunction in Huntington&#x2019;s disease: Intersection of glutamate, dopamine and calcium.</article-title> <source><italic>Future Neurol.</italic></source> <volume>5</volume> <fpage>735</fpage>&#x2013;<lpage>756</lpage>. <pub-id pub-id-type="doi">10.2217/fnl.10.41</pub-id> <pub-id pub-id-type="pmid">21977007</pub-id></citation></ref>
<ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Milnerwood</surname> <given-names>A. J.</given-names></name> <name><surname>Gladding</surname> <given-names>C. M.</given-names></name> <name><surname>Pouladi</surname> <given-names>M. A.</given-names></name> <name><surname>Kaufman</surname> <given-names>A. M.</given-names></name> <name><surname>Hines</surname> <given-names>R. M.</given-names></name> <name><surname>Boyd</surname> <given-names>J. D.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington&#x2019;s disease mice.</article-title> <source><italic>Neuron</italic></source> <volume>65</volume> <fpage>178</fpage>&#x2013;<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2010.01.008</pub-id> <pub-id pub-id-type="pmid">20152125</pub-id></citation></ref>
<ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Milnerwood</surname> <given-names>A. J.</given-names></name> <name><surname>Raymond</surname> <given-names>L. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Early synaptic pathophysiology in neurodegeneration: Insights from Huntington&#x2019;s disease.</article-title> <source><italic>Trends Neurosci.</italic></source> <volume>33</volume> <fpage>513</fpage>&#x2013;<lpage>523</lpage>.</citation></ref>
<ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mochida</surname> <given-names>S.</given-names></name></person-group> (<year>2022</year>). <article-title>Mechanisms of synaptic vesicle exo- and endocytosis.</article-title> <source><italic>Biomedicines</italic></source> <volume>10</volume>:<issue>1593</issue>.</citation></ref>
<ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murthy</surname> <given-names>V. N.</given-names></name> <name><surname>Sejnowski</surname> <given-names>T. J.</given-names></name> <name><surname>Stevens</surname> <given-names>C. F.</given-names></name></person-group> (<year>1997</year>). <article-title>Heterogeneous release properties of visualized individual hippocampal synapses.</article-title> <source><italic>Neuron</italic></source> <volume>18</volume> <fpage>599</fpage>&#x2013;<lpage>612</lpage>. <pub-id pub-id-type="doi">10.1016/s0896-6273(00)80301-3</pub-id> <pub-id pub-id-type="pmid">9136769</pub-id></citation></ref>
<ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paraskevopoulou</surname> <given-names>F.</given-names></name> <name><surname>Parvizi</surname> <given-names>P.</given-names></name> <name><surname>Senger</surname> <given-names>G.</given-names></name> <name><surname>Tuncbag</surname> <given-names>N.</given-names></name> <name><surname>Rosenmund</surname> <given-names>C.</given-names></name> <name><surname>Yildirim</surname> <given-names>F.</given-names></name></person-group> (<year>2021</year>). <article-title>Impaired inhibitory GABAergic synaptic transmission and transcription studied in single neurons by Patch-seq in Huntington&#x2019;s disease.</article-title> <source><italic>Proc. Natl. Acad. Sci. U. S. A.</italic></source> <volume>18</volume>:<issue>e2020293118</issue>. <pub-id pub-id-type="doi">10.1073/pnas.2020293118</pub-id> <pub-id pub-id-type="pmid">33952696</pub-id></citation></ref>
<ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>C.</given-names></name> <name><surname>Chen</surname> <given-names>X.</given-names></name> <name><surname>Tian</surname> <given-names>C. L.</given-names></name> <name><surname>Park</surname> <given-names>G. N.</given-names></name> <name><surname>Chenouard</surname> <given-names>N.</given-names></name> <name><surname>Lee</surname> <given-names>H.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Unique dynamics and exocytosis properties of GABAergic synaptic vesicles revealed by three-dimensional single vesicle tracking.</article-title> <source><italic>Proc. Natl. Acad. Sci. U. S. A.</italic></source> <volume>118</volume>:<issue>e2022133118</issue>. <pub-id pub-id-type="doi">10.1073/pnas.2022133118</pub-id> <pub-id pub-id-type="pmid">33622785</pub-id></citation></ref>
<ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>C.</given-names></name> <name><surname>Jung</surname> <given-names>S.</given-names></name> <name><surname>Park</surname> <given-names>H.</given-names></name></person-group> (<year>2022</year>). <article-title>Single vesicle tracking for studying synaptic vesicle dynamics in small central synapses.</article-title> <source><italic>Curr. Opin. Neurobiol.</italic></source> <volume>76</volume>:<issue>102596</issue>.</citation></ref>
<ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>H.</given-names></name></person-group> (<year>2018</year>). <article-title>Cortical axonal secretion of BDNF in the striatum is disrupted in the mutant-huntingtin knock-in mouse model of Huntington&#x2019;s disease.</article-title> <source><italic>Exp. Neurobiol.</italic></source> <volume>27</volume> <fpage>217</fpage>&#x2013;<lpage>225</lpage>. <pub-id pub-id-type="doi">10.5607/en.2018.27.3.217</pub-id> <pub-id pub-id-type="pmid">30022873</pub-id></citation></ref>
<ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname> <given-names>H.</given-names></name> <name><surname>Li</surname> <given-names>Y.</given-names></name> <name><surname>Tsien</surname> <given-names>R. W.</given-names></name></person-group> (<year>2012</year>). <article-title>Influence of synaptic vesicle position on release probability and exocytotic fusion mode.</article-title> <source><italic>Science</italic></source> <volume>335</volume> <fpage>1362</fpage>&#x2013;<lpage>1366</lpage>. <pub-id pub-id-type="doi">10.1126/science.1216937</pub-id> <pub-id pub-id-type="pmid">22345401</pub-id></citation></ref>
<ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname> <given-names>T. L.</given-names></name> <name><surname>Hansen</surname> <given-names>S.</given-names></name> <name><surname>Kloster</surname> <given-names>M.</given-names></name></person-group> (<year>1973</year>). <article-title>Huntington&#x2019;s chorea. Deficiency of gamma-aminobutyric acid in brain.</article-title> <source><italic>New Engl. J. Med.</italic></source> <volume>288</volume> <fpage>337</fpage>&#x2013;<lpage>342</lpage>.</citation></ref>
<ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname> <given-names>X.</given-names></name> <name><surname>Tsien</surname> <given-names>R. W.</given-names></name> <name><surname>Park</surname> <given-names>H.</given-names></name></person-group> (<year>2019</year>). <article-title>Real-time three-dimensional tracking of single synaptic vesicles reveals that synaptic vesicles undergoing kiss-and-run fusion remain close to their original fusion site before reuse.</article-title> <source><italic>Biochem. Biophys. Res. Commun.</italic></source> <volume>514</volume> <fpage>1004</fpage>&#x2013;<lpage>1008</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2019.05.043</pub-id> <pub-id pub-id-type="pmid">31092326</pub-id></citation></ref>
<ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raymond</surname> <given-names>L. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Striatal synaptic dysfunction and altered calcium regulation in Huntington disease.</article-title> <source><italic>Biochem. Biophys. Res. Commun.</italic></source> <volume>483</volume> <fpage>1051</fpage>&#x2013;<lpage>1062</lpage>.</citation></ref>
<ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raymond</surname> <given-names>L. A.</given-names></name> <name><surname>Andre</surname> <given-names>V. M.</given-names></name> <name><surname>Cepeda</surname> <given-names>C.</given-names></name> <name><surname>Gladding</surname> <given-names>C. M.</given-names></name> <name><surname>Milnerwood</surname> <given-names>A. J.</given-names></name> <name><surname>Levine</surname> <given-names>M. S.</given-names></name></person-group> (<year>2011</year>). <article-title>Pathophysiology of Huntington&#x2019;s disease: Time-dependent alterations in synaptic and receptor function.</article-title> <source><italic>Neuroscience</italic></source> <volume>198</volume> <fpage>252</fpage>&#x2013;<lpage>273</lpage>.</citation></ref>
<ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reiner</surname> <given-names>A.</given-names></name> <name><surname>Deng</surname> <given-names>Y. P.</given-names></name></person-group> (<year>2018</year>). <article-title>Disrupted striatal neuron inputs and outputs in Huntington&#x2019;s disease.</article-title> <source><italic>CNS Neurosci. Ther.</italic></source> <volume>24</volume> <fpage>250</fpage>&#x2013;<lpage>280</lpage>.</citation></ref>
<ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro</surname> <given-names>F. M.</given-names></name> <name><surname>Vieira</surname> <given-names>L. B.</given-names></name> <name><surname>Pires</surname> <given-names>R. G.</given-names></name> <name><surname>Olmo</surname> <given-names>R. P.</given-names></name> <name><surname>Ferguson</surname> <given-names>S. S.</given-names></name></person-group> (<year>2017</year>). <article-title>Metabotropic glutamate receptors and neurodegenerative diseases.</article-title> <source><italic>Pharmacol. Res.</italic></source> <volume>115</volume> <fpage>179</fpage>&#x2013;<lpage>191</lpage>.</citation></ref>
<ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Richards</surname> <given-names>D. A.</given-names></name> <name><surname>Bai</surname> <given-names>J.</given-names></name> <name><surname>Chapman</surname> <given-names>E. R.</given-names></name></person-group> (<year>2005</year>). <article-title>Two modes of exocytosis at hippocampal synapses revealed by rate of FM1-43 efflux from individual vesicles.</article-title> <source><italic>J. Cell Biol.</italic></source> <volume>168</volume> <fpage>929</fpage>&#x2013;<lpage>939</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200407148</pub-id> <pub-id pub-id-type="pmid">15767463</pub-id></citation></ref>
<ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roos</surname> <given-names>R. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Huntington&#x2019;s disease: A clinical review.</article-title> <source><italic>Orphanet J. Rare Dis.</italic></source> <volume>5</volume>:<issue>40</issue>.</citation></ref>
<ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname> <given-names>T. A.</given-names></name> <name><surname>Smith</surname> <given-names>S. J.</given-names></name></person-group> (<year>1995</year>). <article-title>Vesicle pool mobilization during action potential firing at hippocampal synapses.</article-title> <source><italic>Neuron</italic></source> <volume>14</volume> <fpage>983</fpage>&#x2013;<lpage>989</lpage>.</citation></ref>
<ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sawant</surname> <given-names>N.</given-names></name> <name><surname>Morton</surname> <given-names>H.</given-names></name> <name><surname>Kshirsagar</surname> <given-names>S.</given-names></name> <name><surname>Reddy</surname> <given-names>A. P.</given-names></name> <name><surname>Reddy</surname> <given-names>P. H.</given-names></name></person-group> (<year>2021</year>). <article-title>Mitochondrial abnormalities and synaptic damage in huntington&#x2019;s disease: A focus on defective mitophagy and mitochondria-targeted therapeutics.</article-title> <source><italic>Mol. Neurobiol.</italic></source> <volume>58</volume> <fpage>6350</fpage>&#x2013;<lpage>6377</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-021-02556-x</pub-id> <pub-id pub-id-type="pmid">34519969</pub-id></citation></ref>
<ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Serranilla</surname> <given-names>M.</given-names></name> <name><surname>Woodin</surname> <given-names>M. A.</given-names></name></person-group> (<year>2021</year>). <article-title>Striatal chloride dysregulation and impaired GABAergic signaling due to cation-chloride cotransporter dysfunction in Huntington&#x2019;s disease.</article-title> <source><italic>Front. Cell. Neurosci.</italic></source> <volume>15</volume>:<issue>817013</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2021.817013</pub-id> <pub-id pub-id-type="pmid">35095429</pub-id></citation></ref>
<ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>R.</given-names></name> <name><surname>Brundin</surname> <given-names>P.</given-names></name> <name><surname>Li</surname> <given-names>J. Y.</given-names></name></person-group> (<year>2005</year>). <article-title>Synaptic dysfunction in Huntington&#x2019;s disease: A new perspective.</article-title> <source><italic>Cell. Mol. Life Sci.</italic></source> <volume>62</volume> <fpage>1901</fpage>&#x2013;<lpage>1912</lpage>.</citation></ref>
<ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith-Dijak</surname> <given-names>A. I.</given-names></name> <name><surname>Sepers</surname> <given-names>M. D.</given-names></name> <name><surname>Raymond</surname> <given-names>L. A.</given-names></name></person-group> (<year>2019</year>). <article-title>Alterations in synaptic function and plasticity in Huntington disease.</article-title> <source><italic>J. Neurochem.</italic></source> <volume>150</volume> <fpage>346</fpage>&#x2013;<lpage>365</lpage>.</citation></ref>
<ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spokes</surname> <given-names>E. G.</given-names></name> <name><surname>Garrett</surname> <given-names>N. J.</given-names></name> <name><surname>Rossor</surname> <given-names>M. N.</given-names></name> <name><surname>Iversen</surname> <given-names>L. L.</given-names></name></person-group> (<year>1980</year>). <article-title>Distribution of GABA in post-mortem brain tissue from control, psychotic and Huntington&#x2019;s chorea subjects.</article-title> <source><italic>J. Neurol. Sci.</italic></source> <volume>48</volume> <fpage>303</fpage>&#x2013;<lpage>313</lpage>. <pub-id pub-id-type="doi">10.1016/0022-510x(80)90103-3</pub-id> <pub-id pub-id-type="pmid">6449563</pub-id></citation></ref>
<ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tyebji</surname> <given-names>S.</given-names></name> <name><surname>Hannan</surname> <given-names>A. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Synaptopathic mechanisms of neurodegeneration and dementia: Insights from Huntington&#x2019;s disease.</article-title> <source><italic>Prog. Neurobiol.</italic></source> <volume>153</volume> <fpage>18</fpage>&#x2013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2017.03.008</pub-id> <pub-id pub-id-type="pmid">28377290</pub-id></citation></ref>
<ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Virlogeux</surname> <given-names>A.</given-names></name> <name><surname>Moutaux</surname> <given-names>E.</given-names></name> <name><surname>Christaller</surname> <given-names>W.</given-names></name> <name><surname>Genoux</surname> <given-names>A.</given-names></name> <name><surname>Bruyere</surname> <given-names>J.</given-names></name> <name><surname>Fino</surname> <given-names>E.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Reconstituting corticostriatal network on-a-chip reveals the contribution of the presynaptic compartment to Huntington&#x2019;s disease.</article-title> <source><italic>Cell Rep.</italic></source> <volume>22</volume> <fpage>110</fpage>&#x2013;<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2017.12.013</pub-id> <pub-id pub-id-type="pmid">29298414</pub-id></citation></ref>
<ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vonsattel</surname> <given-names>J. P.</given-names></name> <name><surname>DiFiglia</surname> <given-names>M.</given-names></name></person-group> (<year>1998</year>). <article-title>Huntington disease.</article-title> <source><italic>J. Neuropathol. Exp. Neurol.</italic></source> <volume>57</volume> <fpage>369</fpage>&#x2013;<lpage>384</lpage>.</citation></ref>
<ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Welzel</surname> <given-names>O.</given-names></name> <name><surname>Henkel</surname> <given-names>A. W.</given-names></name> <name><surname>Stroebel</surname> <given-names>A. M.</given-names></name> <name><surname>Jung</surname> <given-names>J.</given-names></name> <name><surname>Tischbirek</surname> <given-names>C. H.</given-names></name> <name><surname>Ebert</surname> <given-names>K.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Systematic heterogeneity of fractional vesicle pool sizes and release rates of hippocampal synapses.</article-title> <source><italic>Biophys. J.</italic></source> <volume>100</volume> <fpage>593</fpage>&#x2013;<lpage>601</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpj.2010.12.3706</pub-id> <pub-id pub-id-type="pmid">21281573</pub-id></citation></ref>
<ref id="B71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>W&#x00F3;jtowicz</surname> <given-names>A. M.</given-names></name> <name><surname>Dvorzhak</surname> <given-names>A.</given-names></name> <name><surname>Semtner</surname> <given-names>M.</given-names></name> <name><surname>Grantyn</surname> <given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Reduced tonic inhibition in striatal output neurons from Huntington mice due to loss of astrocytic GABA release through GAT-3.</article-title> <source><italic>Front. Neural Circ.</italic></source> <volume>7</volume>:<issue>188</issue>. <pub-id pub-id-type="doi">10.3389/fncir.2013.00188</pub-id> <pub-id pub-id-type="pmid">24324407</pub-id></citation></ref>
<ref id="B72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>C.</given-names></name> <name><surname>Li</surname> <given-names>C. H.</given-names></name> <name><surname>Chen</surname> <given-names>S.</given-names></name> <name><surname>Yoo</surname> <given-names>H.</given-names></name> <name><surname>Qin</surname> <given-names>X.</given-names></name> <name><surname>Park</surname> <given-names>H.</given-names></name></person-group> (<year>2018</year>). <article-title>Decreased BDNF release in cortical neurons of a knock-in mouse model of Huntington&#x2019;s disease.</article-title> <source><italic>Sci. Rep.</italic></source> <volume>8</volume>:<issue>16976</issue>. <pub-id pub-id-type="doi">10.1038/s41598-018-34883-w</pub-id> <pub-id pub-id-type="pmid">30451892</pub-id></citation></ref>
<ref id="B73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>C.</given-names></name> <name><surname>Zhang</surname> <given-names>M.</given-names></name> <name><surname>Qin</surname> <given-names>X.</given-names></name> <name><surname>Yang</surname> <given-names>X.</given-names></name> <name><surname>Park</surname> <given-names>H.</given-names></name></person-group> (<year>2016</year>). <article-title>Real-time imaging of single synaptic vesicles in live neurons.</article-title> <source><italic>Front. Biol.</italic></source> <volume>11</volume> <fpage>109</fpage>&#x2013;<lpage>118</lpage>. <pub-id pub-id-type="doi">10.3791/2151</pub-id> <pub-id pub-id-type="pmid">20972416</pub-id></citation></ref>
<ref id="B74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Q.</given-names></name> <name><surname>Cao</surname> <given-names>Y. Q.</given-names></name> <name><surname>Tsien</surname> <given-names>R. W.</given-names></name></person-group> (<year>2007</year>). <article-title>Quantum dots provide an optical signal specific to full collapse fusion of synaptic vesicles.</article-title> <source><italic>PNAS</italic></source> <volume>104</volume> <fpage>17843</fpage>&#x2013;<lpage>17848</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0706906104</pub-id> <pub-id pub-id-type="pmid">17968015</pub-id></citation></ref>
<ref id="B75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zuccato</surname> <given-names>C.</given-names></name> <name><surname>Cattaneo</surname> <given-names>E.</given-names></name></person-group> (<year>2009</year>). <article-title>Brain-derived neurotrophic factor in neurodegenerative diseases.</article-title> <source><italic>Nat. Rev. Neurol.</italic></source> <volume>5</volume> <fpage>311</fpage>&#x2013;<lpage>322</lpage>.</citation></ref>
<ref id="B76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zuccato</surname> <given-names>C.</given-names></name> <name><surname>Cattaneo</surname> <given-names>E.</given-names></name></person-group> (<year>2014</year>). <article-title>Huntington&#x2019;s disease.</article-title> <source><italic>Handb. Exp. Pharmacol.</italic></source> <volume>220</volume> <fpage>357</fpage>&#x2013;<lpage>409</lpage>.</citation></ref>
</ref-list>
</back>
</article>
